SEC Tracker
Get the app

Standard Biotools LAB

Standard BioTools sells Microfluidics to ARCHIMED

Form
8-K
Filed
Importance
Routine
  1. Agreement signed on Oct 5, 2026
  2. Sale expected to close in 30 days
  3. ARCHIMED is a healthcare-focused investment firm

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Standard Biotools files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Aquestive Therapeutics AQST public float $292M, Jun 30, 2025
  2. Siga Technologies SIGA public float $302M, Jun 30, 2025
  3. Ocugen OCGN public float $279M, Jun 30, 2025
  4. Abeona Therapeutics ABEO public float $273M, Jun 30, 2025
  5. Tonix Pharmaceuticals Holding TNXP public float $271M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.